[Endometrioid carcinoma of the prostate: a histogenetic dilemma with therapeutic implications].
An additional case of endometrioid carcinoma of the prostate is presented. We discuss the origin and significance of this controversial and uncommon tumor type. The different histogenic hypotheses that have been put forward not only imply a distinct embryologic conception but also an appropriate therapeutic approach. The good results achieved by antiandrogen therapy in the case reported herein have prompted us to consider this treatment modality as a valid adjunct to surgery.
Angulo Cuesta
J
J
Servicios de Urología y Anatomía Patológica, Santo Hospital de Basurto, Bilbao, España.
López
J I
JI
Unda Urzaiz
M
M
Eizaguirre Zarza
B
B
Flores Corral
N
N
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017373:Cyproterone Acetate; D004715:Endometriosis / Q000196:embryology / Q000473:pathology* / Q000628:therapy; D006801:Humans; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000196:embryology / Q000473:pathology* / Q000628:therapy
D000726:Androgen Antagonists; D017373:Cyproterone Acetate; D003534:Cyproterone
Carcinoma endometrioide de la próstata: un dilema histogenético con implicaciones terapéuticas.